z-logo
open-access-imgOpen Access
Olanzapine-induced neutropenia
Author(s) -
Kirti Malhotra,
Priscilla Vu,
Danielle H. Wang,
Hank Lai,
Lawrence Faziola
Publication year - 2015
Publication title -
mental illness
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.239
H-Index - 10
eISSN - 2036-7465
pISSN - 2036-7457
DOI - 10.4081/mi.2015.5871
Subject(s) - olanzapine , neutropenia , clozapine , adverse effect , medicine , antipsychotic , intensive care medicine , atypical antipsychotic , psychiatry , pharmacology , schizophrenia (object oriented programming) , chemotherapy
Olanzapine-induced neutropenia is a rare adverse effect that is currently poorly described in literature. Although neutropenia is a known adverse effect of clozapine, it has been associated with the use of other antipsychotic medications like olanzapine. This case report describes and reviews a case of olanzapine-induced neutropenia in a schizophrenic patient. Although the mechanism of antipsychotic-induced neutropenia is still debated, this report attempts to discuss current theories as well as supply evidence in literature of this rare but potentially dangerous adverse effect

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom